Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

CLDI

Calidi Biotherapeutics Inc

Dec 20 • 04:00PM ET

1.36

Dollar change -0.09
Percentage change -6.21	%

Healthcare • Biotechnology • USA • AMEX

Peers: BNTX MRNA GILD VRTX REGN BMY AMGN PFE JNJ LLY

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.81	Insider Own	11.10%	Shs Outstand	93.11M	Perf Week	-26.49%
Market Cap	24.04M	Forward P/E	-	EPS next Y	-0.78	Insider Trans	-0.51%	Shs Float	16.76M	Perf Month	-40.61%
Income	-27.95M	PEG	-	EPS next Q	-0.37	Inst Own	1.63%	Short Float	5.48%	Perf Quarter	22.52%
Sales	0.00M	P/S	-	EPS this Y	78.64%	Inst Trans	-39.31%	Short Ratio	0.60	Perf Half Y	-27.27%
Book/sh	-0.11	P/B	-	EPS next Y	79.03%	ROA	-208.17%	Short Interest	0.92M	Perf Year	-92.44%
Cash/sh	0.11	P/C	12.02	EPS next 5Y	-	ROE	-238.50%	52W Range	0.73 - 18.50	Perf YTD	-90.99%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-92.65%	Beta	1.13
Dividend TTM	-	Quick Ratio	0.19	Sales past 5Y	-50.00%	Gross Margin	-	52W Low	86.30%	ATR (14)	0.25
Dividend Ex-Date	-	Current Ratio	0.19	EPS Y/Y TTM	45.23%	Oper. Margin	-	RSI (14)	35.60	Volatility	15.71% 12.07%
Employees	41	Debt/Eq	-	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.50	Target Price	6.25
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	95.43%	Payout	-	Rel Volume	0.94	Prev Close	1.45
Sales Surprise	-	EPS Surprise	24.02%	Sales Q/Q	-	Earnings	Nov 12 AMC	Avg Volume	1.53M	Price	1.36
SMA20	-28.18%	SMA50	-18.56%	SMA200	-38.70%	Trades		Volume	1,436,691	Change	-6.21%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-22-23	Initiated	H.C. Wainwright	Buy	$11
Oct-09-23	Initiated	Robert W. Baird	Outperform	$9

Nov-18-24 08:00AM	Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer (GlobeNewswire) +7.31%
Nov-15-24 04:05PM	Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock (GlobeNewswire) +8.96%
Nov-14-24 08:30AM	Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock (GlobeNewswire) -40.53%
Nov-13-24 04:33PM	Calidi Biotherapeutics Announces Proposed Public Offering (GlobeNewswire) +60.19%
Nov-12-24 05:29PM	Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results (GlobeNewswire) +26.35%
09:00AM	Loading…
Oct-25-24 09:00AM	Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV (ACCESSWIRE) +29.76%
Oct-24-24 08:35AM	Calidi to sell 2.05M shares at $1.00 in registered direct offering (TipRanks)
08:30AM	Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences (GlobeNewswire)
Oct-23-24 08:31AM	Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement (GlobeNewswire) -26.54%
Oct-19-24 05:48PM	Calidi Biotherapeutics Faces Warrant Delisting by NYSE (TipRanks)
Oct-18-24 11:00PM	NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS) (GlobeNewswire) -7.38%
08:45AM	Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV (ACCESSWIRE)
Sep-30-24 08:00AM	Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma (GlobeNewswire) -5.79%
Aug-13-24 05:37PM	Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results (GlobeNewswire) -5.71%
Aug-02-24 09:00AM	GreenPower Motor and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV (ACCESSWIRE) -8.38%
09:00AM	Loading…
Jul-29-24 09:00AM	Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor (GlobeNewswire)
Jul-18-24 08:00AM	Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform (GlobeNewswire) -8.43%
Jul-16-24 08:00AM	Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board (GlobeNewswire) +7.42%
Jul-05-24 04:15PM	Calidi to Effect Reverse Stock Split (Business Wire) -18.30%
Jun-27-24 07:00AM	Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors (Business Wire)
Jun-11-24 04:05PM	Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13 (Business Wire) +31.71% -16.67%
Jun-10-24 07:00AM	Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidis Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors (Business Wire) +6.22%
Jun-03-24 07:00AM	Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting (Business Wire) +15.79%
May-31-24 08:51AM	Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds (Business Wire) -36.67%
May-24-24 09:00AM	ASP Isotopes and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV (ACCESSWIRE)
May-17-24 09:00AM	Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV (ACCESSWIRE) -5.99%
May-14-24 04:05PM	Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results (Business Wire)
May-07-24 09:15AM	Sidoti Events, LLC's Virtual May Micro-Cap Conference (ACCESSWIRE) +7.95%
May-01-24 07:00AM	Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting (Business Wire)
Apr-23-24 07:00AM	Join Calidi Biotherapeutics Exclusive Live Investor Webinar and Q&A Session on April 24 (Business Wire) +7.05%
04:05PM	Loading…
Apr-19-24 04:05PM	Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering (Business Wire)
Apr-16-24 08:31AM	Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering (Business Wire) -65.48%
Apr-09-24 07:00AM	Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Companys Novel Immunotherapies at the AACR Annual Meeting 2024 (Business Wire) +62.39%
Mar-15-24 04:05PM	Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results (Business Wire) -5.81%
Mar-11-24 07:00AM	Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer (Business Wire)
Feb-12-24 07:00AM	Calidi Biotherapeutics to Highlight Novel Systemic Enveloped Oncolytic Virotherapy Platform Designed to Target All Tumor Sites at Upcoming Conference (Business Wire)
Jan-08-24 07:00AM	Calidi Biotherapeutics Announces the Appointment of Three New Members to its Scientific and Medical Advisory Board (Business Wire) +6.84%
Dec-13-23 07:00AM	Calidi Biotherapeutics Announces Presentation of Clinical Study for NeuroNova with Recurrent High Grade Glioma at the 8th Oncolytic Virotherapy Summit (Business Wire)
Dec-12-23 07:00AM	Calidi Biotherapeutics Announces Appointment of Pharmaceutical Industry Veteran David LaPré to its Board of Directors (Business Wire)
Nov-20-23 07:00AM	Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform and Updates Anticipated Clinical Milestones (Business Wire)
Nov-14-23 04:05PM	Calidi Biotherapeutics Reports Third Quarter 2023 Operating and Financial Results (Business Wire) -6.98%
Nov-03-23 07:00AM	Calidi Biotherapeutics (NYSEAM: CLDI) Presents Data on CLD-201 Demonstrating Inhibition of Tumor Growth and Induction of Robust Anti-Tumor Immunity at the Society for Immunotherapy of Cancers 38th Annual Meeting (SITC 2023) (Business Wire) +18.90%
Nov-01-23 07:00AM	Calidi Biotherapeutics Announces Key Leadership Promotions and New Board Appointment (Business Wire) -10.55%
Oct-30-23 07:00AM	Calidi Biotherapeutics Announces Appointment of Andrew Jackson as Chief Financial Officer (Business Wire) -13.19%
Oct-10-23 07:00AM	Calidi Biotherapeutics To Present New Preclinical Data Highlighting Cell-based Virotherapy (SuperNova) Platform Technology at SITC 2023 (Business Wire)
Sep-13-23 05:50AM	Calidi Biotherapeutics Debuts as a Publicly Traded Company Focused on Arming the Immune System to Fight Cancer with a New Generation of Targeted Immunotherapies (GlobeNewswire) -38.75%
Sep-11-23 04:05PM	First Light Acquisition Group Announces NYSE Approval for Listing of Business Combination with Calidi Biotherapeutics and Additional New Capital Commitments (GlobeNewswire) -5.66%
Aug-24-23 12:06PM	FIRST LIGHT ACQUISITION GROUP, INC. Further Adjourns Special Meeting of Stockholders to August 28, 2023 at 10:30 am ET (GlobeNewswire)
Aug-22-23 11:41AM	FIRST LIGHT ACQUISITION GROUP, INC. Adjourns Special Meeting of Stockholders to August 24, 2023 at 10:30 am ET (GlobeNewswire) -10.85%
Aug-16-23 06:00AM	Flag Stockholders: Reminder to Vote for Proposed Business Combination (GlobeNewswire)
Aug-07-23 05:00AM	First Light Acquisition Group, Inc. Announces Effectiveness of Registration Statement and Sets August 22, 2023 as Date of Stockholder Meeting for the Calidi Business Combination (GlobeNewswire)
Jun-23-23 05:00AM	Calidi Biotherapeutics Announces Commitment of $25 Million in Series B Funding to Advance Stem Cell-Based Platforms for the Delivery and Potentiation of Oncolytic Viruses to Treat Cancer (GlobeNewswire)

Calidi Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in stem cell-based platforms to revolutionize oncolytic virotherapies. The company was founded in 2014 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Camaisa Allan	CEO and Chairman of the Board	Dec 17 '24	Sale	1.62	10,000	16,200	66,712	Dec 18 09:29 PM
Schoeneck James A	Director	Jun 03 '24	Option Exercise	0.20	548,000	109,600	963,887	Jun 05 04:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CLDI

Calidi Biotherapeutics Inc

Upgrade your FINVIZ experience